Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$400K Buy
5,295
+379
+8% +$28.5K 0.01% 417
2025
Q4
$366K Buy
4,916
+45
+0.9% +$3.29K 0.01% 415
2025
Q3
$329K Buy
4,871
+1,438
+42% +$95.5K 0.01% 441
2025
Q2
$224K Buy
+3,433
New +$206K 0.01% 563

Other funds holding HOLX

Journey Strategic Wealth's HOLX Position: Q1 2026 in Review

Journey Strategic Wealth increased its Hologic (HOLX) stake by 7.7% in Q1 2026, buying an estimated $28.5K and bringing the position to 5,295 shares worth $400K. The position accounts for 0.01% of the portfolio, ranked #417.

Journey Strategic Wealth first reported a position in HOLX in Q2 2025 and has held it in 4 quarters since. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Journey Strategic Wealth held 5,295 shares of Hologic worth $400K as of Q1 2026.
  • Journey Strategic Wealth bought 379 Hologic shares in Q1 2026, an estimated $28.5K.
  • Hologic made up 0.01% of Journey Strategic Wealth's portfolio in Q1 2026, its #417 holding.
  • Journey Strategic Wealth first reported a position in Hologic in Q2 2025 and has held it in 4 quarters since.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.